About John M. Goldman
John M. Goldman (30 November 1938 – 24 December 2013) was a British haematologist, oncologist and medical researcher. A specialist in chronic myeloid leukaemia, Goldman conducted pioneering research into leukaemia treatment – he was instrumental in the development of bone marrow transplantation as a clinical method, and later in the development of the drug imatinib. John Goldman attended the Westminster School and performed in the school choir, but was barred from singing in Westminster Abbey, likely due to his Jewish background.
Biography source: Wikipedia. The profile adds birthday-specific historical context from the Celebs Birthday Today editorial database.